KCNN4 and glioma: The later findings corroborate a recent report that KCa3.1 inhibition with TRAM‐34 can switch the phenotype of glioma infiltrating microglia/macrophages away from a tumor‐promoting to a more pro‐inflammatory anti‐tumor phenotype (Grimaldi et al., 2016).